AACR 2012 intro

Article

CancerNetwork brings exclusive coverage of the AACR Annual Meeting, held March 31-April 4, 2012 at McCormick Place in Chicago, Illinois. The meeting will highlight the best and latest findings in all major areas of cancer research. This year's theme is “Accelerating Science: Concept to Clinic,” reflecting the progress and emphasizing the synergy between basic, clinical, and translational research that will continue to lead to effective cancer therapies and prevention strategies. Check below for the most important news to come out of this year's event.

 

CancerNetwork brings exclusive coverage of the AACR Annual Meeting, held March 31-April 4, 2012 at McCormick Place in Chicago, Illinois. The meeting will highlight the best and latest findings in all major areas of cancer research. This year's theme is “Accelerating Science: Concept to Clinic,” reflecting the progress and emphasizing the synergy between basic, clinical, and translational research that will continue to lead to effective cancer therapies and prevention strategies.

Check below for the most important news to come out of this year's event.

Recent Videos
Greater direct access to academic oncologists may help address challenges associated with a lack of CAR T education in the community setting.
Brett L. Ecker, MD, discusses the importance of multidisciplinary collaboration in improving patient outcomes in neuroendocrine tumors.
2 experts are featured in this series.
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Related Content
A computational linguistics model designed to locate pancreatic cysts that started to locate pancreatic cancer has the potential to lead to more efficient treatment.

AI Software Learns to Identify Pancreatic Cancer Vs Cysts

Russell C. Langan, MD
November 26th 2024
Article

A computational linguistics model designed to locate pancreatic cysts that started to locate pancreatic cancer has the potential to lead to more efficient treatment.

Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.

Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer

Tanios S. Bekaii-Saab, MD, FACP
November 25th 2024
Podcast

Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.

For patients with KRAS-mutated colorectal cancer, onvansertib plus FOLFIRI/bevacizumab was effective in those who had not received prior bevacizumab.

Onvansertib Combo Shows Significant Efficacy in KRAS+ Colorectal Cancer

Tim Cortese
November 26th 2024
Article

For patients with KRAS-mutated colorectal cancer, onvansertib plus FOLFIRI/bevacizumab was effective in those who had not received prior bevacizumab.

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

Collaboration Fosters Treatment Advancements for Young Lymphoma Populations

Andrew M. Evens, DO, MS
November 18th 2024
Podcast

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

A computational linguistics model has mitigated disparities in surveillance of the pancreas that primarily affected racial and ethnic minorities.

Bridging Racial and Ethnic Minority Disparities in Pancreatic Cyst Surveillance

Russell C. Langan, MD
November 25th 2024
Article

A computational linguistics model has mitigated disparities in surveillance of the pancreas that primarily affected racial and ethnic minorities.

Site Logo

SPM AE Incidence After CAR T-Cell Therapy in Lymphoma and Myeloma

American Society for Transplantation and Cellular Therapy
November 25th 2024
Article

Findings from the Phase 3 AURIGA trial support the use of lenalidomide plus daratumumab vs lenalidomide alone as post-transplant maintenance therapy for patients with newly diagnosed multiple myeloma.